The cumulative incidence of later severe neutropenia and/or treatment with G-CSF (since some patients were treated with G-CSF prior to having an ANC < 0.5 × 109/L) after day ten post-CAR T infusion was 24% and 29% at 30- and 90-days, respectively. Here, CSF3 is linked to neutropenia.